SYLENTIS SAU

Patent Applications and Registrations

Patent applications and USPTO patent grants for SYLENTIS SAU.The latest application filed is for "sirna and their use in methods and compositions for inhibiting the expression of the orai1 gene".

Company Profile

3.12.9

SYLENTIS SAU - Madrid ES

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
siRNA and their use in methods and compositions for inhibiting the expression of the NRARP gene Grant 10,752,896 - Jimenez , et al. A	2020-08-25
siRNA And Their Use In Methods And Compositions For Inhibiting The Expression Of The ORAI1 Gene App 20190106700 - Jimenez; Ana Isabel ; et al.	2019-04-11
SiRNA and their use in methods and compositions for inhibiting the expression of the ORAI1 gene Grant 10,167,473 - Jimenez , et al. J	2019-01-01
Sirna And Their Use In Methods And Compositions For Inhibiting The Expression Of The Nrarp Gene App 20180340177 - JIMENEZ; Ana Isabel ; et al.	2018-11-29
SiRNAs and their use in methods and compositions for the treatment and/or prevention of eye conditions Grant 10,011,837 - Anton , et al. July 3, 2	2018-07-03
SiRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions Grant 10,011,832 - Anton , et al. July 3, 2	2018-07-03
siRNA and their use in methods and compositions for inhibiting the expression of the PDK1 gene Grant 9,951,338 - Jimenez , et al. April 24, 2	2018-04-24
SiRNA and their use in methods and compositions for the treatment and / or prevention of eye conditions Grant 9,808,479 - Anton , et al. November 7, 2	2017-11-07
siRNAs and Their Use in Methods and Compositions for the Treatment and/or Prevention of Eye Conditions App 20170058279 - Anton; Ana Isabel Jimenez ; et al.	2017-03-02
siRNA AND THEIR USE IN METHODS AND COMPOSITIONS FOR INHIBITING THE EXPRESSION OF THE FLAP GENE App 20160304867 - JIMENEZ; Ana Isabel ; et al.	2016-10-20
siRNA AND THEIR USE IN METHODS AND COMPOSITIONS FOR INHIBITING THE EXPRESSION OF THE ORAI1 GENE App 20160304880 - JIMENEZ; Ana Isabel ; et al.	2016-10-20
siRNA AND THEIR USE IN METHODS AND COMPOSITIONS FOR INHIBITING THE EXPRESSION OF THE PDK1 GENE App 20160237440 - JIMENEZ; Ana Isabel ; et al.	2016-08-18
siRNA and their use in methods and compositions for the treatment and / or prevention of eye conditions App 20150259677 - Anton; Ana Isabel Jimenez ; et al.	2015-09-17
siRNA and their use in methods and compositions for the treatment and / or prevention of eye conditions App 20150224131 - Anton; Ana Isabel Jimenez ; et al.	2015-08-13
Methods and compositions for the treatment of eye disorders with increased intraocular pressure Grant 8,247,386 - Jimenez , et al. August 21, 2	2012-08-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.